MAPLE GROVE HOSPITAL — History
CCN 240214 | 3-year financial timeline | COVID resilience: 79/100
🛡️ Public data only — no PHI permitted on this instance.
$250M
Latest Revenue (FY2022)
+11.4%
Revenue CAGR (3yr)
13.5%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $201M | $234M | $250M | +6.8% | +11.4% |
| Operating Expenses | $181M | $198M | $216M | +9.2% | +9.0% |
| Operating Margin | 9.7% | 15.4% | 13.5% | -12.2% | +18.0% |
| Net Income | $20M | $36M | $34M | -6.3% | +31.5% |
| Licensed Beds | 134 | 138 | 148 | +7.2% | +5.1% |
| Total Patient Days | 38,218 | 42,491 | 43,632 | +2.7% | +6.8% |
| Medicare Day % | 8% | 7% | 9% | +16.7% | +4.1% |
| Medicaid Day % | 11% | 8% | 9% | +13.4% | -7.1% |
COVID Impact & Recovery
Resilience Score: 79/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +24.1% ($201M → $250M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▲ Growing
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+11.4%
This Hospital
+7.6%
State Avg
Latest Margin
13.5%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $274M | 15.5% |
| FY2024 (proj) | $298M | 17.4% |
| FY2025 (proj) | $322M | 19.3% |